Covidien to pay $17.5M for False Claims Act violations
Covidien has agreed to pay $17.5 million for violations of the False Claims Act by providing free or discounted practice development and market development support to physicians in California and Florida to induce purchases of Covidien products, the Department of Justice announced.
Related articles
-
ArticleAstellas, Amgen to pay $124.75M for False Claims Act violations
Pharmaceutical companies Astellas and Amgen will pay a total of $124.75 million to resolve allegations that they violated the False Claims Act by illegally paying the Medicare co-pays for their own high-priced drugs.
-
ArticleRansomware gang BlackSuit hit with major takedown after targeting 450 U.S. victims
The BlackSuit ransomware organization has taken a major hit under a U.S.-led, global law enforcement operation that seized the criminal group’s servers and assets, the Department of Justice said Monday.
-
News BriefDOJ declines to prosecute Liberty Mutual in $4.7M FCPA bribery case
Liberty Mutual agreed to give up $4.7 million in profit – the amount it earned from a bribery scheme uncovered by the government – as part of a settlement related to the Foreign Corrupt Practices Act, according to a letter from the U.S. Department of Justice.
More from Regulatory Enforcement
-
ArticleNation’s largest apartment manager agrees to end use of RealPage algorithm
Greystar Management, the largest apartment manager in the U.S., has agreed to halt its use of a certain algorithm program to set prices under a Department of Justice proposed settlement aimed at ending the company’s alleged rental price fixing.
-
ArticleFraud, money laundering, and sanctions prompt global regulators to increase scrutiny of law firms
Legal firms face growing global regulatory pressure, requiring compliance managers to focus on integrated systems, identity verification, and staff training to prevent crime and penalties.
-
ArticleFTC secures $145 Million in settlements over misleading health insurance sales and data practices
Two major health insurance brokers will pay a combined $145 million to resolve Federal Trade Commission allegations that they misled millions of consumers and mishandled personal data, the agency announced Thursday.